Citations

Mayo Clinic

Clear

473 citation(s) found for "Wallace, J D".

The “Cough Trick:” A Brief Strategy to Manage Pediatric Pain From Immunization Injections
Wallace, Dustin P. , Allen, Keith D. , Lacroix, Amy E., Pitner, Sheryl L., Wallace, Dustin P

Pediatrics | January 12, 2010 | Volume: 125 | Issue: 2 | Pages: e367-e373

10.1542/peds.2009-0539 | PMID 20064862 Get It

OBJECTIVE:The goal was to investigate the effect of a “cough trick” technique on self-reported pain of children receiving routine immunizations. The strategy requires minimal equipment, time, or training for parents, children, and nursing staff members.METHODS:A randomized, controlled, unblinded, within-subject study of 68 children receiving prekindergarten (ages 4–5) or pre–junior high school (ages 11–13) immunizations was performed. Participants were recruited from an outpatient pediatric clinic at a large public hospital in the Midwest. The strategy required a single “warm-up” cough of moderate force, followed by a second cough that coincided with needle puncture. The principle outcome was self-reported pain, although parent and nurse report of pain was used to support the accuracy of self-report. Older participants and all nurses completed a measure of their satisfaction with the procedure.RESULTS:In the initial analysis, the procedure was found not to be effective. However, post hoc tests revealed that the procedure was effective at a statistically and clinically significant level for participants identified as Hispanic white or non-Hispanic white but not for those identified as non-Hispanic black. Participants and clinic nurses found the procedure acceptable and effective.CONCLUSIONS:The results of this study suggest that the cough trick can be an effective strategy for the reduction of pain for some children undergoing routine immunizations. However, additional research is needed to clarify the observed moderation by self-identified race.
A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
Jin, Zhe , Cheng, Yulan , Gu, Wen , Sato, Fumiaki , Mori, Yuriko , Olaru, Alexandru, Paun, Bogdan C., Kan, Takatsugu, Ito, Tetsuo, Hamilton, James P. , Selaru, Florin M. , Agarwal, Rachana , David, Stefan, Abraham, John , Wolfsen, Herbert C. , Wallace, Michael B. , Shaheen, Nicholas J. , Washington, Kay, Bhattacharyya, Achyut, Nelson, Mark A. , Romero, Yvonne , Wang, Kenneth K. , Feng, Ziding , Sampliner, Richard E., Meltzer, Stephen J. , Zheng, Yingye , Yang, Jian Ping , Wang, Jean , Canto, Marcia Irene , Wagner, Paul Daniel , Wallace, Michael B , Meltzer, Stephen J

Cancer Research | May 12, 2009 | Volume: 69 | Issue: 10 | Pages: 4112-4115

10.1158/0008-5472.can-09-0028 | PMID 19435894 Get It

Abstract Esophageal adenocarcinoma risk in Barrett's esophagus (BE) is increased 30- to 125-fold versus the general population. Among all BE patients, however, neoplastic progression occurs only once per 200 patient-years. Molecular biomarkers are therefore needed to risk-stratify patients for more efficient surveillance endoscopy and to improve the early detection of progression. We therefore performed a retrospective, multicenter, double-blinded validation study of eight BE progression prediction methylation biomarkers. Progression or nonprogression were determined at 2 years (tier 1) and 4 years (tier 2). Methylation was assayed in 145 nonprogressors and 50 progressors using real-time quantitative methylation-specific PCR. Progressors were significantly older than nonprogressors (70.6 versus 62.5 years; P < 0.001). We evaluated a linear combination of the eight markers, using coefficients from a multivariate logistic regression analysis. Areas under the ROC curve (AUC) were high in the 2-year, 4-year, and combined data models (0.843, 0.829, and 0.840; P < 0.001, <0.001, and <0.001, respectively). In addition, even after rigorous overfitting correction, the incremental AUCs contributed by panels based on the 8 markers plus age versus age alone were substantial (Δ-AUC = 0.152, 0.114, and 0.118, respectively) in all 3 models. A methylation biomarker–based panel to predict neoplastic progression in BE has potential clinical value in improving both the efficiency of surveillance endoscopy and the early detection of neoplasia. [Cancer Res 2009;69(10):4112–5]
Pilot Study on Light Dosimetry Variables for Photodynamic Therapy of Barrett's Esophagus with High-Grade Dysplasia
Gill, Kanwar R. , Wolfsen, Herbert C. , Preyer, Norris W., Scott, Marquitta V., Gross, Seth A., Wallace, Michael B. , Jones, Linda, Wallace, Michael B

Clinical Cancer Research | February 25, 2009 | Volume: 15 | Issue: 5 | Pages: 1830-1836

10.1158/1078-0432.ccr-08-2317 | PMID 19240171 Get It

Abstract Purpose: Photodynamic therapy (PDT) is used to treat Barrett's esophagus with high-grade dysplasia and mucosal carcinoma. Outcomes are variable with some patients having persistent disease, whereas others develop strictures. The aims of this study were (a) to compare porfimer sodium tissue uptake, light dose, and esophageal thickness with clinical outcomes and (b) to determine the selectivity of porfimer sodium uptake in diseased and normal epithelium. Experimental Design: Forty-eight hours after porfimer sodium infusion, patients underwent mucosal biopsy for quantification of the porfimer sodium. Laser light was delivered at 48 hours and again 24 or 48 hours later. Porfimer sodium was extracted from the biopsy samples and quantified using fluorescence spectroscopy. The enhanced photodynamic dose was determined as [porfimer sodium content * light dose/esophageal thickness]. PDT efficacy was determined 6 to 8 weeks later based on persistence or complete ablation of dysplasia or carcinoma. Results: Mean porfimer sodium content of 6.2 mg/kg (range, 2.6-11.2 mg/kg) and mean total light dose of 278 J/cm (range, 225-360 J/cm) resulted in a complete treatment. Mean porfimer sodium tissue content of 3.9 mg/kg (range, 2.1-8.1 mg/kg) and mean total light dose of 268 J/cm (range, 250-350 J/cm) resulted in an incomplete treatment. The total esophageal thickness (range, 1.7-6.0 mm) and enhanced photodynamic dose were correlated with treatment outcome. Conclusions: Esophageal thickness is the strongest predictor of treatment outcome. The porfimer sodium content of Barrett's and normal tissue is not significantly different. “Photodynamic dose” for esophageal PDT should incorporate the esophageal thickness.
Pilot Study of Transesophageal Endoscopic Surgery: NOTES Esophagomyotomy, Vagotomy, Lymphadenectomy
Woodward, Timothy A., McCluskey, David, Wallace, Michael B. , Raimondo, Massimo , Mannone, John, Smith, C. Daniel , Wallace, Michael B

Journal of Laparoendoscopic & Advanced Surgical Techniques | September 26, 2008 | Volume: 18 | Issue: 5 | Pages: 743-745

10.1089/lap.2008.0226 | PMID 18803520 Get It

Elderly Women Diagnosed with Nonspecific Chest Pain May Be at Increased Cardiovascular Risk
Robinson, Jennifer G. , Wallace, Robert K. , Limacher, Marian C. , Sato, Alicia , Cochrane, Barbara B. , Ockene, Judith K. , Blanchette, Patricia Lanoie , Ko, Marcia G., Wassertheil-Smoller, Sylvia W

Journal of Women's Health | January 2, 2007 | Volume: 15 | Issue: 10 | Pages: 1151-1160

10.1089/jwh.2006.15.1151 | PMID 17199456 Get It

Physical Mapping of a Translocation Breakpoint in Neurofibromatosis
Fountain, Jane W., BRUCE, M, Seizinger, Bernd R., Menon, Anil G. , Gusella, James F. , Michels, Virginia V., Schmidt, Michael A. , Dewald, Gordon W., Collins, Francis S. , Wallace, Margaret R.

Science | October 5, 2006 | Volume: 244 | Issue: 4908 | Pages: 1085-1087

10.1126/science.2543076 | PMID 2543076 Get It

The gene for von Recklinghausen neurofibromatosis (NF1), one of the most common autosomal-dominant disorders of humans, was recently mapped to chromosome 17 by linkage analysis. The identification of two NF1 patients with balanced translocations that involved chromosome 17q11.2 suggests that the disease can arise by gross rearrangement of the NF1 locus, and that the NF1 gene might be identified by cloning the region around these translocation breakpoints. To further define the region of these translocations, a series of chromosome 17 Not I-linking clones has been mapped to proximal 17q and studied by pulsed-field gel electrophoresis. One clone, 17L1 (D17S133), clearly identifies the breakpoint in an NF1 patient with a t(1;17) translocation. A 2.3-megabase pulsed-field map of this region was constructed and indicates that the NF1 breakpoint is only 10 to 240 kilobases away from 17L1. This finding prepares the way for the cloning of NF1 .
Ultrasonic and computed tomographic imaging of the abdominal aorta
Hattery, Robert R., Williamson, Byrn, Wallace, Robert B.

World Journal of Surgery | May 11, 2006 | Volume: 4 | Issue: 5 | Pages: 511-518

10.1007/bf02401617 | PMID 6894508 Get It

AbstractAlthough ultrasonic and computed tomographic technology is continuing to evolve, these already sophisticated imaging tests have become the primary methods of evaluating the patients with aortic aneurysms. Both modalities are accurate and noninvasive. The major value of these techniques to the surgeon is in assessing those patients in whom the diagnosis is in doubt and in following patients in whom it has been elected to observe a small stable aneurysm. Changes in an aneurysm can be detected on serial examinations which might indicate the need for surgery in spite of adverse patient risk factors, and these techniques may provide a means of detecting false aneurysms in patients who are difficult to assess accurately by physical examination. Ultrasound and computed tomography are very helpful techniques in the diagnosis and assessment of aortic aneurysms. These diagnostic modalities are not required in every patient and should be used discriminately and when indicated.
Polyphasic Characterization Reveals that the Human Pathogen Mycobacterium peregrinum Type II Belongs to the Bovine Pathogen Species Mycobacterium senegalense
Wallace, Richard J. , Brown‐Elliott, Barbara A. , Brown, June M., Steigerwalt, Arnold G., Hall, Leslie, Woods, Gail L. , Cloud, Joann L. , Mann, Linda, Wilson, Rebecca W., Crist, Christopher J., Jost, Kenneth, Byrer, Dorothy E., Tang, Jane, Cooper, Jason, Stamenova, Elena K., Campbell, Brian A., Wolfe, Joyce, Turenne, Christine Y. , Turenne, Christine Y

Journal of Clinical Microbiology | December 6, 2005 | Volume: 43 | Issue: 12 | Pages: 5925-5935

10.1128/jcm.43.12.5925-5935.2005 | PMID 16333077 Get It

ABSTRACT Mycobacterium peregrinum consists of two taxa: types I and II. We evaluated 43 clinical type II strains from throughout the United States. They were responsible for soft-tissue and bone infections, catheter-related infections, and possible pneumonitis. By carbohydrate utilization, they were indistinguishable from type I strains, being d -mannitol and trehalose positive. However, they had a distinct susceptibility pattern that included intermediate ciprofloxacin MICs but low clarithromycin and doxycycline MICs of ≤1 μg/ml. These features were also shared by reference isolates of Mycobacterium senegalense from African bovine cases of “farcy.” By 16S rRNA gene sequencing, the type II isolates shared 100% sequence identity with M. senegalense . Partial sequencing of the type II hsp65 gene (441 bp) revealed four sequevars showing ≥98.4% identity with each other and ≥98.6% identity with the sequence of five bovine strains of M. senegalense . There was ≤97.1% identity with M. peregrinum type I isolates and other Mycobacterium fortuitum group species. Sequencing of additional gene targets including the 16S-23S rDNA internal transcribed spacer region and the rpoB gene (partial sequence) revealed a similar phylogenetic grouping. DNA-DNA hybridization showed 76 to 99% relatedness between the bovine and human strains. These studies demonstrate that type II isolates are not isolates of M. peregrinum but represent human strains of M. senegalense . This study is the first to demonstrate this species as a human pathogen. Representative human M. senegalense strains include ATCC 35755 and newly submitted strains ATCC BAA-849, ATCC BAA-850, and ATCC BAA-851.
Workshop Report: Prevention of Postoperative Recurrence in Crohn's Disease
Markowitz, James , Markowitz, Jonathan E. , Bousvaros, Athos, Crandall, Wallace, Faubion, William A. , Kirschner, Barbara S. , Perrault, Jean, Rosh, Joel R. , Winter, Harland S.

Journal of Pediatric Gastroenterology and Nutrition | July 28, 2005 | Volume: 41 | Issue: 2 | Pages: 145-151

10.1097/01.mpg.0000172746.86973.ef | PMID 16056092 Get It

Differential Inhibition of Neuronal Na+–Ca2+Exchange versus  Store-operated Ca2+Channels by Volatile Anesthetics in Pheochromocytoma (PC12) Cells
Ay, Binnaz, Wallace, Daniel, Mantilla, Carlos B. , Prakash, Y. S. , Prakash, Y S , Mantilla, Carlos B

Anesthesiology | June 27, 2005 | Volume: 103 | Issue: 1 | Pages: 93-101

10.1097/00000542-200507000-00016 | PMID 15983461 Get It

Background Ca2+ influx is a key component of neuronal intracellular Ca2+ ([Ca2+]i) regulation. The authors hypothesized that volatile anesthetic inhibition of neuronal activity is mediated by inhibition of Ca2+ influx via two major mechanisms: plasma membrane Na+-Ca2+ exchange (NCX) and the novel mechanism of Ca2+ influx triggered by endoplasmic reticulum Ca2+ depletion (store-operated Ca2+ channels [SOCCs]). Methods Differentiated rat pheochromocytoma cells loaded with the Ca2+ indicator fura-2 were Na+-loaded with 0 Ca2+, 145 mm Na+ Tyrode's and 5 microm cyclopiazonic acid plus 10 microm ryanodine (functionally isolating plasma membrane). Influx-mode NCX was rapidly reactivated by 0 Na+ and 2.5 mm Ca2+. The protocol was repeated in the presence of volatile anesthetics (0.5-1.5 minimum alveolar concentration [MAC] halothane, isoflurane, or sevoflurane) or other drugs to characterize NCX. To examine SOCCs, endoplasmic reticulum Ca2+ was depleted by cyclopiazonic acid in 0 extracellular Ca2+, and Ca2+ influx was triggered by rapid reintroduction of extracellular Ca2+. The protocol was repeated in the presence of anesthetics or other drugs to characterize SOCCs. Results Influx via NCX was not inhibited by voltage-gated Ca2+ channel blockers but was sensitive to NCX inhibitors. Halothane and isoflurane (0.5-1.5 MAC) significantly inhibited NCX (P < 0.05; paired comparisons), whereas sevoflurane at less than 1.5 MAC did not inhibit NCX. SOCC-mediated Ca2+ influx was insensitive to a variety of Ca2+ channel blockers but was inhibited by Ni2+. Such influx was sensitive only to halothane at greater than 1 MAC but not isoflurane or sevoflurane. Conclusions These data indicate that volatile anesthetics, especially halothane and isoflurane, interfere with neuronal [Ca2+]i regulation by inhibiting NCX but not SOCC-mediated Ca2+ influx (except high concentrations of halothane).